Lord, Abbett & Co. LLC
- SEC CIK
- 0000728100
- Latest filing
- Aug 14, 2026
ELVN holding history
Enliven Therapeutics, Inc. in every 13F filed by Lord, Abbett & Co. LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ELVN overviewAll 13F holders of ELVNFull Q2 2026 holdings
- Shares (Q2 2026)
- 330,759
- Value
- $16.8M
- % of portfolio
- <0.1%
- Quarters held
- 4
- Since Q3 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 330,759 | $16.8M | <0.1% | +330,759 | New | Holders |
| Q2 2025 | 0 | $0 | 0.0% | −197,279−100.0% | Sold out | Holders |
| Q1 2025 | 197,279 | $3.88M | <0.1% | −188,932−48.9% | Reduced | Holders |
| Q4 2024 | 386,211 | $8.69M | <0.1% | +65,156+20.3% | Added | Holders |
| Q3 2024 | 321,055 | $8.20M | <0.1% | +321,055 | New | Holders |